716 resultados para Best practice
Resumo:
INTRODUCTION: The International Neuromodulation Society (INS) has determined that there is a need for guidance regarding safety and risk reduction for implantable neurostimulation devices. The INS convened an international committee of experts in the field to explore the evidence and clinical experience regarding safety, risks, and steps to risk reduction to improve outcomes. METHODS: The Neuromodulation Appropriateness Consensus Committee (NACC) reviewed the world literature in English by searching MEDLINE, PubMed, and Google Scholar to evaluate the evidence for ways to reduce risks of neurostimulation therapies. This evidence, obtained from the relevant literature, and clinical experience obtained from the convened consensus panel were used to make final recommendations on improving safety and reducing risks. RESULTS: The NACC determined that the ability to reduce risk associated with the use of neurostimulation devices is a valuable goal and possible with best practice. The NACC has recommended several practice modifications that will lead to improved care. The NACC also sets out the minimum training standards necessary to become an implanting physician. CONCLUSIONS: The NACC has identified the possibility of improving patient care and safety through practice modification. We recommend that all implanting physicians review this guidance and consider adapting their practice accordingly.
Resumo:
For more than 20 years, measurement of catecholamines in plasma and urine in clinical chemistry laboratories has been the cornerstone of the diagnosis of neuroendocrine tumors deriving from the neural crest such as pheochromocytoma (PHEO) and neuroblastoma (NB), and is still used to assess sympathetic stress function in man and animals. Although assay of catecholamines in urine are still considered the biochemical standard for the diagnosis of NB, they have been progressively abandoned for excluding/confirming PHEOs to the advantage of metanephrines (MNs). Nevertheless, catecholamine determinations are still of interest to improve the biochemical diagnosis of PHEO in difficult cases that usually require a clonidine-suppression test, or to establish whether a patient with PHEO secretes high concentrations of catecholamines in addition to metanephrines. The aim of this chapter is to provide an update about the catecholamine assays in plasma and urine and to show the most common pre-analytical and analytical pitfalls associated with their determination.
Resumo:
Program newsletter used to communicate with parents and professionals about newborn hearing screening in Iowa, including best practice and family stories.
Resumo:
Program newsletter used to communicate with parents and professionals about newborn hearing screening in Iowa, including best practice and family stories.
Resumo:
Program newsletter used to communicate with parents and professionals about newborn hearing screening in Iowa, including best practice and family stories.
Resumo:
Program newsletter used to communicate with parents and professionals about newborn hearing screening in Iowa, including best practice and family stories.
Resumo:
Program newsletter used to communicate with parents and professionals about newborn hearing screening in Iowa, including best practice and family stories.
Resumo:
Program newsletter used to communicate with parents and professionals about newborn hearing screening in Iowa, including best practice and family stories.
Resumo:
Program newsletter used to communicate with parents and professionals about newborn hearing screening in Iowa, including best practice and family stories.
Resumo:
Program newsletter used to communicate with parents and professionals about newborn hearing screening in Iowa, including best practice and family stories.
Resumo:
Program newsletter used to communicate with parents and professionals about newborn hearing screening in Iowa, including best practice and family stories.
Resumo:
Program newsletter used to communicate with parents and professionals about newborn hearing screening in Iowa, including best practice and family stories.
Resumo:
Program newsletter used to communicate with parents and professionals about newborn hearing screening in Iowa, including best practice and family stories.
Resumo:
Program newsletter used to communicate with parents and professionals about newborn hearing screening in Iowa, including best practice and family stories.
Resumo:
Program newsletter used to communicate with parents and professionals about newborn hearing screening in Iowa, including best practice and family stories.
